BREVAGen™ Cleared for Sale into Florida
September 25, 2012
Melbourne, Australia; -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) is pleased to announce that BREVAGen™ has been cleared for sale into the State of Florida following the grant of a permit to the Company’s Australian-based laboratory by the Clinical Laboratory Unit of the Florida Agency for Healthcare Administration (“AHCA”). This news follows the Company’s [...]
September 25, 2012
Codolet, France, and Bedford, MA, - Cisbio Bioassays (www.cisbio.com), global developer of products, technologies and services used for assay development and drug screening and for in vitro diagnostics, announces the launch of its epigenetics toolbox for use in drug discovery research. Epigenetics is a crucial field of study for the pharmaceutical and biotechnology industries due [...]
Neogen reports record first quarter revenue and net income
September 25, 2012
LANSING, Mich., – Neogen Corporation (Nasdaq: NEOG) announced today that its net income for the first quarter of FY 2013, which ended Aug. 31, increased 11.8% from the prior year to $6,714,000, or $0.28 per share. This compares to net income of $6,004,000 in the first quarter of FY 2012, or $0.25 per share. First [...]
September 25, 2012
SOUTH SAN FRANCISCO, Calif. –– Fluidigm Corporation (NASDAQ:FLDM) today announced it has joined AMDeC (Academy for Medical Development and Collaboration) as a Vendor Partner. This will provide Fluidigm with easy access to almost 20 of the pre-eminent medical research institutions in the New York region through AMDeC’s unique online resource - AMDeC F.I.R.S.T. - while [...]
LECO and Genedata Collaborate on Mass Spectrometry Data Analysis for High Resolution TOFMS Systems
September 25, 2012
St. Joseph, Mich., and Basel, Switz.——Genedata, a leading provider of advanced software solutions for drug discovery and life science research, and LECO, a global leader in analytical instrumentation and mass spectrometers, have announced their collaboration, which brings to market Genedata Expressionist® MSX software compatibility with LECO High Resolution TOFMS (HRT) instrumentation. Designed for complex sample [...]
Innovative Quality Control Device Approved for Use in Multiple Volatile Environments
September 25, 2012
(Research Triangle Park, N.C.) Analytical instrumentation innovator Mustard Tree Instruments (R) is proud to announce that its Verifier (TM) Process System 1000 (VPS-1000) in-process material verification tool has achieved Class 1, Division 1, Group B, C, and D certification. The new certification expands the uses of the VPS-1000 for fast, reliable, non-contact, non-destructive chemical identification [...]
Life Technologies Launches Pervenio™ Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
September 25, 2012
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ:LIFE) today announced the launch of Pervenio™ Lung RS. First-of-its-kind, the molecular test has been documented to reliably identify early stage lung cancer patients who are at high risk for mortality following surgery. It also fulfills an unmet need for prognostic information to guide preventative treatment and improve disease [...]
Brooks Life Science Systems Launch the Plate Auditor™ for Automated Compound Quality Control
September 25, 2012
POWAY, CA, – Brooks Life Science Systems, a division of Brooks Automation, Inc. (Nasdaq: BRKS), a leading worldwide provider of automation solutions for compound and biological sample storage and management, today announced the commercial launch of the Brooks Plate Auditor™, a fast, accurate and non-invasive tool for identification of precipitate and empty wells in compound [...]
Avacta selects Trinean’s DropSense96® for purified protein QC
September 25, 2012
Ghent, Belgium – Trinean, the leading provider of microfluidic spectrophotometry platforms, today announced that its DropSense96® droplet reader has been chosen by Avacta for High Throughput analysis of their purified Affimer proteins. Avacta has established facilities capable of expressing and purifying 15,000 of their proprietary Affimer proteins every 6 weeks. These affinity reagents, which can [...]
A personal approach to cancer treatment
September 25, 2012
Cambridge, UK and MA –– Innovative technology design and development firm Cambridge Consultants is working with Singapore-based Clearbridge BioMedics on a groundbreaking device to improve cancer testing and research. The innovative second-generation ClearCellTM System enables tumor cells to be retrieved and detected even faster, and potentially more accurately, from a simple blood sample – paving [...]

